earnings
DR
NASDAQ · DRMA
Dermata Therapeutics, Inc.
Healthcare · Biotechnology
$0.78
Down-$0.07 (-7.86%)
Updated Nov 1, 2026, 1:39 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.9M
- P/E ratio
- -0.32
- Dividend yield
- 0.00%
- 52-week range
- $0.60 – $4.66
- Volume
- 62.2K
- Avg. volume
- 196.69K
Price performance · DRMA
DRMA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
DRMA closed at $0.78 after 20 trading sessions, down 30.18% for the selected period.
- Last close
- $0.78
- Period change
- -30.18%
- Period low
- $0.66
- Period high
- $1.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $0.799 | $0.829 | $0.7632 | $0.775 | 62.2K |
| Oct 29, 2026 | $0.88 | $0.88 | $0.8211 | $0.8411 | 32.22K |
| Oct 28, 2026 | $0.77 | $0.8904 | $0.7501 | $0.8747 | 169.92K |
| Oct 27, 2026 | $0.736 | $0.7697 | $0.6727 | $0.755 | 188.39K |
| Oct 26, 2026 | $0.759 | $0.78 | $0.7033 | $0.718 | 114.63K |
| Oct 23, 2026 | $0.8331 | $0.8497 | $0.7717 | $0.781 | 124.96K |
| Oct 22, 2026 | $0.78 | $0.87 | $0.78 | $0.864 | 140.28K |
| Oct 21, 2026 | $0.8501 | $0.8898 | $0.7817 | $0.7995 | 222.82K |
| Oct 20, 2026 | $0.8554 | $0.9275 | $0.83 | $0.8699 | 185.13K |
| Oct 19, 2026 | $0.8478 | $0.9701 | $0.76 | $0.8599 | 852.47K |
| Oct 16, 2026 | $0.909 | $0.9504 | $0.81 | $0.86 | 2.52M |
| Oct 15, 2026 | $0.7685 | $1.18 | $0.7658 | $0.91 | 170.52M |
| Oct 14, 2026 | $0.86 | $0.86 | $0.6032 | $0.6633 | 350.75K |
| Oct 13, 2026 | $0.8901 | $0.90 | $0.84 | $0.8599 | 40.09K |
| Oct 12, 2026 | $1.0001 | $1.0102 | $0.8867 | $0.8896 | 44.91K |
| Oct 9, 2026 | $1.08 | $1.08 | $1.01 | $1.02 | 22.52K |
| Oct 8, 2026 | $1.10 | $1.10 | $1.05 | $1.07 | 7.1K |
| Oct 7, 2026 | $1.14 | $1.14 | $1.11 | $1.12 | 7.42K |
| Oct 6, 2026 | $1.12 | $1.145 | $1.11 | $1.13 | 29.59K |
| Oct 5, 2026 | $1.16 | $1.16 | $1.0901 | $1.11 | 14.16K |
Latest DRMA news
The latest Smart Investors Daily articles mentioning DRMA.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

